Literature DB >> 11292102

Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study).

J Garcia-Aymerich1, E Barreiro, E Farrero, R M Marrades, J Morera, J M Antó.   

Abstract

There is little information available concerning the extent to which chronic obstructive pulmonarv disease (COPD) patients are satisfactorily managed, especially, regards factors supposedly related to COPD exacerbation. The present study assessed the prevalence rates of potentially modifiable risk factors of COPD exacerbation in patients hospitalized for this reason. A systematic sample of one out of two patients admitted for COPD exacerbation, during 1 yr, in four tertiary hospitals in the Barcelona area, Spain, was performed. Patients answered a questionnaire and underwent anthropometric measurements, spirometric tests and arterial blood gas sampling. Prevalence rates and 95% confidence intervals (95% CI) for risk factors were obtained, and the generalized estimating equation (GEE) method was used to allow for patients to provide information on different admissions. The study recruited 353 patients (29 female) with a total of 404 admissions age (mean+/-SD) 69+/-9, median forced expiratory volume in one second (FEV1) 31% of predicted and mean partial pressure of oxygen (PO2) 63+/-13 mmHg. Of these, 28% had not received an influenza vaccination; a high number (86%) did not attend rehabilitation programmes; 28% of patients with PO2 < or =55 mmHg were not using long-term oxygen therapy (LTOT); among LTOT users, 18% used it <15 h a day; 43% of the total failed in some of the essential inhaler manoeuvres; 26% were current smokers; 21% of noncurrent smokers were exposed to passive smoking at home; current occupational exposure was low (5%). In summary, the authors found a moderate to high prevalence of potentially modifiable risk factors in a large representative sample of patients hospitalized for a chronic obstructive pulmonary disease exacerbation, suggesting unsatisfactory features in their management.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11292102     DOI: 10.1034/j.1399-3003.2000.16f03.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  31 in total

Review 1.  COPD exacerbations.5: management.

Authors:  R Rodríguez-Roisin
Journal:  Thorax       Date:  2006-06       Impact factor: 9.139

2.  Predictors of Pharmacotherapy for Tobacco Use Among Veterans Admitted for COPD: The Role of Disparities and Tobacco Control Processes.

Authors:  Anne C Melzer; Laura C Feemster; Margaret P Collins; David H Au
Journal:  J Gen Intern Med       Date:  2016-02-22       Impact factor: 5.128

3.  Rapid assessment of the demand and supply of tobacco dependence pharmacotherapy in Uganda.

Authors:  B J Kirenga; R Jones; A Muhofa; G Nyakoojo; S Williams
Journal:  Public Health Action       Date:  2016-02-17

4.  Exploring variables associated with medication non-adherence in patients with COPD.

Authors:  Anan S Jarab; Tareq L Mukattash
Journal:  Int J Clin Pharm       Date:  2019-08-30

5.  Patient medication adherence: measures in daily practice.

Authors:  Beena Jimmy; Jimmy Jose
Journal:  Oman Med J       Date:  2011-05

6.  Previous outpatient antibiotic use in patients admitted to hospital for COPD exacerbations: room for improvement.

Authors:  M Miravitlles; J J Soler-Cataluña; F Baranda; P Cordero; J-V Greses; C de la Roza
Journal:  Infection       Date:  2012-08-21       Impact factor: 3.553

7.  Risk factors and outcomes associated with chronic obstructive pulmonary disease exacerbations requiring hospitalization.

Authors:  Katayoun Bahadori; J Mark FitzGerald; Robert D Levy; Tharwat Fera; John Swiston
Journal:  Can Respir J       Date:  2009 Jul-Aug       Impact factor: 2.409

8.  Risk factors of readmission to hospital for a COPD exacerbation: a prospective study.

Authors:  J Garcia-Aymerich; E Farrero; M A Félez; J Izquierdo; R M Marrades; J M Antó
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

Review 9.  Influenza infection and COPD.

Authors:  Patrick Mallia; Sebastian L Johnston
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

Review 10.  Strategies for improving outcomes of COPD exacerbations.

Authors:  Tom Wilkinson; J A Wedzicha
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.